<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>tumor microenvironment immune modulation &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/tumor-microenvironment-immune-modulation/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 17 Oct 2025 16:10:21 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>tumor microenvironment immune modulation &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Radiotherapy-Resistant CAFs Shape Breast Tumor Immunity</title>
		<link>https://bioengineer.org/radiotherapy-resistant-cafs-shape-breast-tumor-immunity/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 17 Oct 2025 16:10:15 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[CAF subtypes (iCAFs]]></category>
		<category><![CDATA[mmCAFs)]]></category>
		<category><![CDATA[prognostic biomarkers for radiotherapy]]></category>
		<category><![CDATA[radiotherapy resistance in breast cancer]]></category>
		<category><![CDATA[single-cell RNA sequencing in oncology]]></category>
		<category><![CDATA[tumor microenvironment immune modulation]]></category>
		<guid isPermaLink="false">https://bioengineer.org/radiotherapy-resistant-cafs-shape-breast-tumor-immunity/</guid>

					<description><![CDATA[In a groundbreaking study poised to reshape breast cancer treatment paradigms, researchers have unveiled the critical role of cancer-associated fibroblasts (CAFs) in driving radiotherapy resistance. Published in BMC Cancer, this integrative analysis dives deep into the tumor microenvironment (TME), revealing how specific CAF subtypes sculpt immune landscapes that undermine therapeutic success. The findings not only [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">282910</post-id>	</item>
	</channel>
</rss>
